Rapid Micro Biosystems (RPID) Accumulated Expenses (2020 - 2026)

Rapid Micro Biosystems has disclosed Accumulated Expenses across 7 years of filings, most recently posting $6.5 million for Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $6.5 million, up 29.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.5 million (up 29.02% YoY), and the FY2025 annual result was $8.3 million, up 15.23% from the prior year.
• Accumulated Expenses came in at $6.5 million for Q1 2026 at Rapid Micro Biosystems, down from $8.3 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $9.9 million in Q4 2023 to a low of $2.3 million in Q2 2022.
• The 5-year median for Accumulated Expenses is $7.0 million (2024), against an average of $6.9 million.
• Across the five-year window, Accumulated Expenses jumped 1107.68% in 2022 and dropped 28.59% in 2025, its largest moves.
• Rapid Micro Biosystems' Accumulated Expenses stood at $8.2 million in 2022, then rose by 21.56% to $9.9 million in 2023, then decreased by 27.15% to $7.2 million in 2024, then climbed by 15.23% to $8.3 million in 2025, then fell by 21.9% to $6.5 million in 2026.
• The last three Accumulated Expenses figures came in at $6.5 million (Q1 2026), $8.3 million (Q4 2025), and $6.6 million (Q3 2025), per Business Quant data.